Zobrazeno 1 - 10
of 34
pro vyhledávání: '"A. N. Krivosheeva"'
Autor:
Elena N. Krivosheeva, Andrey L. Komarov, Elizaveta P. Panchenko, Maria B. Khakimova, Ekaterina S. Kropacheva, Olga A. Pogorelova, Tatyana V. Balakhonova, Elena V. Titaeva, Anatoly B. Dobrovolsky, Damir M. Galyautdinov, Elina E. Vlasova
Publikováno v:
Терапевтический архив, Vol 96, Iss 7, Pp 683-689 (2024)
Aim. To evaluate the prognostic value of GDF-15 in relation the development of bleeding and events in stable CAD patients, receiving combined antithrombotic therapy. Materials and methods. The data was obtained from the prospective registry REGATA
Externí odkaz:
https://doaj.org/article/ab1fc0ec63a84d55b606aeefc59edcd2
Autor:
Olga O. Shakhmatova, Andrey L. Komarov, Elena N. Krivosheeva, Anatoly B. Dobrovolsky, Elena V. Titaeva, Vera A. Amelyushkina, Nataliya V. Gomyranova, Elizaveta P. Panchenko
Publikováno v:
Терапевтический архив, Vol 95, Iss 9, Pp 763-768 (2023)
Background. The role of albuminuria as a marker of the atherosclerosis burden and a predictor of prognosis in patients with polyvascular disease (PD) has been little studied. Aim. To evaluate the prevalence, association with atherosclerosis burden
Externí odkaz:
https://doaj.org/article/4b7168fe5ec34714a30e4f5f29c70ad8
Autor:
M. B. Khakimova, A. L. Komarov, E. N. Krivosheeva, V. M. Mironov, S. K. Kurbanov, S. O. Kuzyakina, E. B. Yarovaya, E. P. Panchenko
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 22, Iss 9 (2023)
Aim. To identify factors determining the prognosis after elective myocardial revascularization in patients with coronary artery disease (CAD) with multifocal atherosclerosis (MFA).Material and methods. The study is based on the prospective registry R
Externí odkaz:
https://doaj.org/article/0346ca9eb63944f3a8d5f8107bf346bc
Autor:
Yu. A. Fedotkina, A. L. Komarov, А. В. Dobrovolsky, E. N. Krivosheeva, О. О. Frolkova, E. V. Titaeva, T. V. Balakhonova, Е. Р. Panchenko
Publikováno v:
Атеротромбоз, Vol 12, Iss 2, Pp 64-78 (2023)
Introduction. Thrombotic complications (TC) in different vascular systems dictate the fate of high-risk patients. In cardiological practice, patients with advanced atherosclerotic vascular disease (MFA) represent the most vulnerable group. Malignant
Externí odkaz:
https://doaj.org/article/2a42b5c63e7743ab8b51a593d268037a
Publikováno v:
Терапевтический архив, Vol 94, Iss 12, Pp 1374-1380 (2023)
Background. It is necessary to strive to resume anticoagulants for patients with atrial fibrillation who have a high risk of thrombosis after the development of large bleeding. Due to the fact that death in these patients is caused not by a recurrenc
Externí odkaz:
https://doaj.org/article/2164a8e952ac4954a2f57cc20550156b
Autor:
Andrey L. Komarov, Elena N. Krivosheeva, Maksim I. Makeev, Evgeny V. Merkulov, Maria I. Tripoten, Elizaveta P. Panchenko
Publikováno v:
Терапевтический архив, Vol 94, Iss 9, Pp 1109-1114 (2022)
А clinical case of a young patient with recurrent ischemic strokes is presented. The problems of diagnostic embolic strokes are discussed. We set out the algorithm for identifying patients, in whom patent foramen ovale is the most probable cause of
Externí odkaz:
https://doaj.org/article/d2d505f0e29040b8aa6e5b519ed9cf49
Autor:
E. N. Krivosheeva, A. L. Komarov, D. M. Galyautdinov, E. E. Vlasova, R. S. Akchurin, E. P. Panchenko
Publikováno v:
Атеротромбоз, Vol 11, Iss 2, Pp 30-43 (2022)
Introduction. Multifocal atherosclerosis (MFA) in patients with CHD is a key risk factor for thrombotic complications (TC). There are little data on the long-term prognosis in patients with multivessel CHD combined with carotid artery lesions.Objecti
Externí odkaz:
https://doaj.org/article/ff790b7b2d4e4407af1a011c7f543fbb
Autor:
Ekaterina S. Kropacheva, Mariia B. Khakimova, Elena N. Krivosheeva, Oksana A. Zemlyanskaya, Elizaveta P. Panchenko
Publikováno v:
Терапевтический архив, Vol 93, Iss 9, Pp 1037-1043 (2021)
Background. The rate of major bleeding in patients with atrial fibrillation receiving oral anticoagulants is 25% per year. Gastrointestinal bleedings are at least a half of major hemorrhagic complications. Currently, there is no optimal scale to calc
Externí odkaz:
https://doaj.org/article/95de1ac080cc44c688844fc284f355f6
Publikováno v:
Атеротромбоз, Vol 0, Iss 1, Pp 68-88 (2021)
Introduction. Despite the large evidence base for the use of rivaroxaban, cohort studies are interesting because shows the possibility of anticoagulant therapy in patients with high thromboembolic and bleeding risk and a burden of comorbidity in prac
Externí odkaz:
https://doaj.org/article/7fc1d804582e418a9a7859e33ae304e9
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 7 (2021)
Aim. To study the predictive value of growth differentiation factor 15 (GDF-15) in patients with atrial fibrillation (AF) after elective percutaneous coronary intervention (PCI).Material and methods. The study included 150 patients (men, 69,3%) with
Externí odkaz:
https://doaj.org/article/ba9a03d5455540a09be2d243a3e156c7